相关实验视频

Updated: Feb 23, 2026

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

使徒RNA传递到小岛β细胞使用结合脂质纳米颗粒

Jacob R Enriquez¹, Zhengjie Zhou², Jennifer B Nelson¹

¹Kovler Diabetes Center and Department of Medicine, Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism, The University of Chicago, Chicago, IL, USA.

Cell reports. Medicine

|February 21, 2026

概括

一种新的脂质纳米粒子 (LNP) 平台有效地将mRNA传递给胰腺β细胞,通过调节免疫反应和保护β细胞,显示出1型糖尿病 (T1D) 治疗的前景.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
内分泌学在内分泌学.

背景情况:

1型糖尿病 (T1D) 需要抑制免疫攻击并保护胰腺β细胞的疗法.
目前的T1D治疗方法在向特定细胞和有效调节免疫反应方面面临挑战.

研究的目的:

开发和评估一种脂质纳米粒子 (LNP) 平台,用于向胰腺β细胞传递向信使RNA (mRNA).
为了增强β细胞向,使用与增强型葡萄糖样-1 (eGLP-1) 的结合.
在T1D的临床前模型中评估这个LNP平台的治疗潜力.

主要方法:

开发用于mRNA输送的LNP配方,包括eGLP-1结合变体.
在实验室中评估LNP在将mRNA输送到小鼠和人类β细胞中的效率.
在C57BL/6J小鼠体内生物分布研究,以评估胰腺和β细胞丰富.
在糖尿病前NOD小鼠中测试LNP介导的PD-L1mRNA传递,以评估免疫调节和糖尿病发病.
在异种岛屿移植模型中对人类β细胞LNP输送的评估.

主要成果:

无论是未结合的还是eGLP结合的LNP都在体外证明了有效地将mRNA传递给β细胞.
在体内研究表明胰腺丰富LNP,eGLP-LNP在小鼠中实现更大的β细胞特异性.
在NOD小鼠中,PD-L1mRNA的LNP输送减弱了胰岛炎和延迟了自身免疫糖尿病发病.
在异种移植模型中,LNPs成功地将mRNA传递给人类β细胞,这表明了翻译潜力.

结论:

已经建立了一个多功能LNP平台,用于向β细胞提供向的mRNA.
eGLP-1结合增强了胰腺β细胞中的LNP积累.
这种LNP平台显示出免疫调节和1型糖尿病治疗干预的潜力.

关键词:

这就是GLP-1.在PD-L1中.糖尿病糖尿病患者糖尿病患者小小的岛屿小小的岛屿脂质纳米颗粒是一种纳米粒子.

更多相关视频

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Published on: May 14, 2019

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer

Published on: October 10, 2012

相关概念视频

Insulin Secretory Vesicles

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

Insulin: Biosynthesis, Chemistry, and Preparation

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...